コンテンツへスキップ
Merck

The evolutionary dynamics of influenza A virus adaptation to mammalian hosts.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences (2013-02-06)
S Bhatt, T T Lam, S J Lycett, A J Leigh Brown, T A Bowden, E C Holmes, Y Guan, J L N Wood, I H Brown, P Kellam, O G Pybus
要旨

Few questions on infectious disease are more important than understanding how and why avian influenza A viruses successfully emerge in mammalian populations, yet little is known about the rate and nature of the virus' genetic adaptation in new hosts. Here, we measure, for the first time, the genomic rate of adaptive evolution of swine influenza viruses (SwIV) that originated in birds. By using a curated dataset of more than 24 000 human and swine influenza gene sequences, including 41 newly characterized genomes, we reconstructed the adaptive dynamics of three major SwIV lineages (Eurasian, EA; classical swine, CS; triple reassortant, TR). We found that, following the transfer of the EA lineage from birds to swine in the late 1970s, EA virus genes have undergone substantially faster adaptive evolution than those of the CS lineage, which had circulated among swine for decades. Further, the adaptation rates of the EA lineage antigenic haemagglutinin and neuraminidase genes were unexpectedly high and similar to those observed in human influenza A. We show that the successful establishment of avian influenza viruses in swine is associated with raised adaptive evolution across the entire genome for many years after zoonosis, reflecting the contribution of multiple mutations to the coordinated optimization of viral fitness in a new environment. This dynamics is replicated independently in the polymerase genes of the TR lineage, which established in swine following separate transmission from non-swine hosts.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ノイラミニダーゼ Clostridium perfringens(ウェルシュ菌)由来, Suitable for manufacturing of diagnostic kits and reagents, Type V, lyophilized powder
Sigma-Aldrich
ノイラミニダーゼ コレラ菌由来, Type III, buffered aqueous solution, 0.2 μm filtered, 1-5 units/mg protein (Lowry, using NAN-lactose)
Sigma-Aldrich
ノイラミニダーゼ コレラ菌由来, Type II, buffered aqueous solution, 8-24 units/mg protein (Lowry, using NAN-lactose)
Sigma-Aldrich
ノイラミニダーゼ Clostridium perfringens(ウェルシュ菌)由来, Type X, lyophilized powder, ≥50 units/mg protein (using 4MU-NANA)
Sigma-Aldrich
α(2→3,6,8,9)ノイラミニダーゼ Arthrobacter ureafaciens由来, recombinant, expressed in E. coli, buffered aqueous solution
Sigma-Aldrich
α(2→3,6,8,9)ノイラミニダーゼ Arthrobacter ureafaciens由来, Proteomics Grade, suitable for MALDI-TOF MS
Sigma-Aldrich
ノイラミニダーゼ Clostridium perfringens(ウェルシュ菌)由来, Type VI, lyophilized powder, 6-15 units/mg protein (using 4MU-NANA), 2-10 units/mg protein (mucin)
Sigma-Aldrich
ノイラミニダーゼ Clostridium perfringens(ウェルシュ菌)由来, Type VIII, lyophilized powder, 10-20 units/mg protein (using 4MU-NANA), 3.5-8.0 units/mg protein (mucin)
Sigma-Aldrich
α(2→3,6)ノイラミニダーゼ Clostridium perfringens(ウェルシュ菌)由来, recombinant, expressed in E. coli, buffered aqueous solution, ≥250 units/mg protein
Sigma-Aldrich
α(2→3)ノイラミニダーゼ 肺炎レンサ球菌由来, buffered aqueous solution
Sigma-Aldrich
ノイラミニダーゼアガロース Clostridium perfringens(ウェルシュ菌)由来, Type VI-A, ammonium sulfate suspension